Literature DB >> 26142100

Some studies on the natural history of Graves' orbitopathy: increase in orbital fat is a rather late phenomenon.

Peter W Potgieser1, Wilmar M Wiersinga2, Noortje I Regensburg2, Maarten P Mourits2.   

Abstract

AIM: To describe volumes of orbital fat (FV) and extraocular muscles (MV) in Graves' orbitopathy (GO) as a function of the duration of GO. PATIENTS: i) Cross-sectional survey among 95 consecutive patients with untreated GO who had been referred to the combined thyroid-eye clinics of our university hospital. ii) Longitudinal survey among 39 of the 95 patients who did not receive any therapeutic intervention and were followed for 1 year.
METHODS: A computed tomography (CT)-based and well-validated method for calculating orbital soft tissues. In order to neutralize sex differences, results are expressed as ratios of FV:orbital volume (OV) and MV:OV.
RESULTS: i) Patients with GO duration of >1 year had greater FV:OV (0.65 vs 0.55, P=0.004), similar MV:OV (0.22 vs 0.21, not significant (NS)), and more proptosis (22 mm vs 21 mm, P=0.03) as compared to those with shorter duration. ii) As compared to baseline, after 1 year, FV:OV had increased (0.56 vs 0.63, P=0.000), MV:OV had not changed (0.19 vs 0.19, NS), proptosis was higher (20 mm vs 21 mm, P=0.003), and clinical activity scores had become lower (2 vs 1, P=0.02) (median values).
CONCLUSION: CT images show that a longer duration of GO is associated with a higher orbital FV. Extraocular MV, however, is not associated with GO duration; rather, it is related to the severity of GO.
© 2015 European Society of Endocrinology.

Entities:  

Mesh:

Year:  2015        PMID: 26142100     DOI: 10.1530/EJE-14-1140

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  12 in total

1.  [Calculation of orbital fat volumes for determining treatment timing for thyroid- associated ophthalmopathy].

Authors:  Wei Jiang; Qiu-Yue Cai; Zhang-Fang Li; Zhi-Yi Chen; Yao-Sheng Luo; Shi-di Hu; Jie Shen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-05-20

Review 2.  The thyroid, the eyes and the gut: a possible connection.

Authors:  D Covelli; M Ludgate
Journal:  J Endocrinol Invest       Date:  2017-01-07       Impact factor: 4.256

3.  [A novel method for quantitative measurement of orbital fat volume based on magnetic resonance images].

Authors:  Qiu-Yue Cai; Zhi-Yi Chen; Wei Jiang; Yao-Sheng Luo; Zhang-Fang Li; Shi-di Hu; Jie Shen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-09-20

4.  Increased Orbital Muscle Fraction Diagnosed by Semi-Automatic Volumetry: A Risk Factor for Severe Visual Impairment with Excellent Response to Surgical Decompression in Graves' Orbitopathy.

Authors:  Christine Steiert; Sebastian Kuechlin; Waseem Masalha; Juergen Beck; Wolf Alexander Lagrèze; Juergen Grauvogel
Journal:  J Pers Med       Date:  2022-06-06

5.  Orbital Fat Volumetry and Water Fraction Measurements Using T2-Weighted FSE-IDEAL Imaging in Patients with Thyroid-Associated Orbitopathy.

Authors:  Y Kaichi; K Tanitame; H Itakura; H Ohno; M Yoneda; Y Takahashi; Y Akiyama; K Awai
Journal:  AJNR Am J Neuroradiol       Date:  2016-06-30       Impact factor: 3.825

6.  Pingmu Decoction Induces Orbital Preadipocytes Apoptosis In Vitro.

Authors:  Yali Zhang; Hong Li; Long Gao; Xia Zhang; RuiFang Xie
Journal:  Evid Based Complement Alternat Med       Date:  2017-04-18       Impact factor: 2.629

7.  Thyroid-associated Orbitopathy: Quantitative Evaluation of the Orbital Fat Volume and Edema Using IDEAL-FSE.

Authors:  Yoko Kaichi; Keizo Tanitame; Hiroaki Terada; Hideki Itakura; Haruya Ohno; Masayasu Yoneda; Yuji Takahashi; Yuji Akiyama; Kazuo Awai
Journal:  Eur J Radiol Open       Date:  2019-05-18

Review 8.  New insights into the pathogenesis and nonsurgical management of Graves orbitopathy.

Authors:  Peter N Taylor; Lei Zhang; George J Kahaly; Marian Ludgate; Richard W J Lee; Ilaria Muller; Daniel G Ezra; Colin M Dayan
Journal:  Nat Rev Endocrinol       Date:  2019-12-30       Impact factor: 43.330

9.  Texture analysis of orbital magnetic resonance imaging for monitoring and predicting treatment response to glucocorticoids in patients with thyroid-associated ophthalmopathy.

Authors:  Yue-Yue Wang; Qian Wu; Lu Chen; Wen Chen; Tao Yang; Xiao-Quan Xu; Fei-Yun Wu; Hao Hu; Huan-Huan Chen
Journal:  Endocr Connect       Date:  2021-06-24       Impact factor: 3.335

10.  Novel Roles of Chloroquine and Hydroxychloroquine in Graves' Orbitopathy Therapy by Targeting Orbital Fibroblasts.

Authors:  Yan Guo; Hai Li; Xueying Chen; Huasheng Yang; Hongyu Guan; Xiaoying He; Yuxin Chen; Sunil Pokharel; Haipeng Xiao; Yanbing Li
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.